Bayer HealthCare AG of Germany has signed a wide-ranging collaboration agreement with Beijing’s Tsinghua University. The two entities will establish the Bayer-Tsinghua (Institute of Biomedicine) Research Center of Innovative Drug Discovery. Serving as Director will be Yigong Shi, PhD, a renowned structural biologist with expertise in protein X-ray crystallography and a focus on apoptosis. Dr. Shi is currently Director of the Department of Biological Sciences and Biotechnology and Vice Dean of the Institute of Biomedicine of Tsinghua University. More details...

Stock Symbol: (Frankfurt: SCH)